American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: General principles

Brachytherapy

Volumn 11, Issue 1, 2012, Pages 33-46

  Viswanathan, Akila N ^a   Thomadsen, Bruce ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Brachytherapy; Cervical cancer; Guidelines

Indexed keywords

ANALGESIC AGENT; ANESTHETIC AGENT; ANTIDIARRHEAL AGENT; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; FLUOROURACIL; PACLITAXEL; SEDATIVE AGENT;

ADVANCED CANCER; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUS SEDATION; CONSENSUS DEVELOPMENT; DOSIMETRY; ECHOGRAPHY; EPIDURAL ANESTHESIA; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; INTERSTITIAL RADIATION; MEDICAL DOCUMENTATION; MEDICAL SOCIETY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION APPLICATOR; RADIATION DOSE; RADIATION DOSE FRACTIONATION; THREE DIMENSIONAL IMAGING; TREATMENT DURATION; TREATMENT PLANNING; UTERINE CERVIX CARCINOMA;

BRACHYTHERAPY; CARCINOMA; FEMALE; HUMANS; PRACTICE GUIDELINES AS TOPIC; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 84856011340     PISSN: 15384721     EISSN: 18731449     Source Type: Journal    
DOI: 10.1016/j.brachy.2011.07.003     Document Type: Article

References (99)

1. Lanciano R.M., Won M., Coia L.R., et al. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: A final report of the 1973 and 1978 patterns of care studies. Int J Radiat Oncol Biol Phys 1991, 20:667-676.
2. Hanks G.E., Herring D.F., Kramer S. Patterns of care outcome studies. Results of the national practice in cancer of the cervix. Cancer 1983, 51:959-967.
3. Coia L., Won M., Lanciano R., et al. The Patterns of Care Outcome Study for cancer of the uterine cervix. Results of the Second National Practice Survey. Cancer 1990, 66:2451-2456.
4. Montana G.S., Martz K.L., Hanks G.E. Patterns and sites of failure in cervix cancer treated in the U.S.A. in 1978. Int J Radiat Oncol Biol Phys 1991, 20:87-93.
5. Potish R.A. The effect of applicator geometry on dose specification in cervical cancer. Int J Radiat Oncol Biol Phys 1990, 18:1513-1520.
6. Perez C.A., Breaux S., Bedwinek J.M., et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications. Cancer 1984, 54:235-246.
7. Corn B.W., Hanlon A.L., Pajak T.F., et al. Technically accurate intracavitary insertions improve pelvic control and survival among patients with locally advanced carcinoma of the uterine cervix. Gynecol Oncol 1994, 53:294-300.
8. Viswanathan A.N., Cormack R., Rawal B., et al. Increasing brachytherapy dose predicts survival for interstitial and tandem-based radiation for stage IIIB cervical cancer. Int J Gynecol Cancer 2009, 19:1402-1406.
9. Viswanathan A., Moughan J.W., Small J., et al. The quality of cervical-cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in RTOG Prospective Trials 0116 and 0128. Int J Radiat Oncol Biol Phys 2010, 75:S86.
10. Erickson B., Eifel P., Moughan J., et al. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): A Patterns of Care study. Int J Radiat Oncol Biol Phys 2005, 63:1083-1092.
11. Eifel P.J., Moughan J., Erickson B., et al. Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: A patterns of care study. Int J Radiat Oncol Biol Phys 2004, 60:1144-1153.
12. Eifel P.J., Moughan J., Owen J., et al. Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: Patterns of care study. Int J Radiat Oncol Biol Phys 1999, 43:351-358.
13. Pecorelli S., Zigliani L., Odicino F. Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet 2009, 105:107-108.
14. Perez C.A., Grigsby P.W., Nene S.M., et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer 1992, 69:2796-2806.
15. Horn L.C., Fischer U., Raptis G., et al. Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. Gynecol Oncol 2007, 107:310-315.
16. Quinn M.A., Benedet J.L., Odicino F., et al. Carcinoma of the cervix uteri. FIGO 6th Annual Report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2006, (95 Suppl. 1):S43-103.
17. Eifel P.J., Jhingran A., Levenback C.F., et al. Predictive value of a proposed subclassification of stages I and II cervical cancer based on clinical tumor diameter. Int J Gynecol Cancer 2009, 19:2-7.
18. Lowrey G.C., Mendenhall W.M., Million R.R. Stage IB or IIA-B carcinoma of the intact uterine cervix treated with irradiation: A multivariate analysis. Int J Radiat Oncol Biol Phys 1992, 24:205-210.
19. Hricak H., Gatsonis C., Coakley F.V., et al. Early invasive cervical cancer: CT and MR imaging in preoperative evaluation-ACRIN/GOG comparative study of diagnostic performance and interobserver variability. Radiology 2007, 245:491-498.
20. Mitchell D.G., Snyder B., Coakley F., et al. Early invasive cervical cancer: Tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study. J Clin Oncol 2006, 24:5687-5694.
21. Kidd E.A., Siegel B.A., Dehdashti F., et al. Lymph node staging by positron emission tomography in cervical cancer: Relationship to prognosis. J Clin Oncol 2010, 28:2108-2113.
22. NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer. v.1; 2010.
23. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999, 340:1137-1143.
24. Esthappan J., Chaudhari S., Santanam L., et al. Prospective clinical trial of positron emission tomography/computed tomography image-guided intensity-modulated radiation therapy for cervical carcinoma with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys 2008, 72:1134-1139.
25. Gerszten K., Colonello K., Heron D.E., et al. Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix. Gynecol Oncol 2006, 102:182-188.
26. Beriwal S., Gan G.N., Heron D.E., et al. Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2007, 68:166-171.
27. Salama J.K., Mundt A.J., Roeske J., et al. Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies. Int J Radiat Oncol Biol Phys 2006, 65:1170-1176.
28. Kavanagh B.D., Pan C.C., Dawson L.A., et al. Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys 2010, 76:S101-S107.
29. Dawson L.A., Kavanagh B.D., Paulino A.C., et al. Radiation-associated kidney injury. Int J Radiat Oncol Biol Phys 2010, 76:S108-S115.
30. van de Bunt L., van der Heide U.A., Ketelaars M., et al. Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: The impact of tumor regression. Int J Radiat Oncol Biol Phys 2006, 64:189-196.
31. van de Bunt L., Jurgenliemk-Schulz I.M., de Kort G.A., et al. Motion and deformation of the target volumes during IMRT for cervical cancer: What margins do we need?. Radiother Oncol 2008, 88:233-240.
32. Taylor A., Powell M.E. An assessment of interfractional uterine and cervical motion: Implications for radiotherapy target volume definition in gynaecological cancer. Radiother Oncol 2008, 88:250-257.
33. Collen C., Engels B., Duchateau M., et al. Volumetric imaging by megavoltage computed tomography for assessment of internal organ motion during radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2010, 77:1590-1595.
34. Beadle B.M., Jhingran A., Salehpour M., et al. Cervix regression and motion during the course of external beam chemoradiation for cervical cancer. Int J Radiat Oncol Biol Phys 2009, 73:235-241.
35. Chan P., Dinniwell R., Haider M.A., et al. Inter- and intrafractional tumor and organ movement in patients with cervical cancer undergoing radiotherapy: A cinematic-MRI point-of-interest study. Int J Radiat Oncol Biol Phys 2008, 70:1507-1515.
36. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999, 340:1154-1161.
37. Rose P.G., Ali S., Watkins E., et al. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: A Gynecologic Oncology Group Study. J Clin Oncol 2007, 25:2804-2810.
38. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999, 340:1144-1153.
39. Eifel P.J., Winter K., Morris M., et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 2004, 22:872-880.
40. Whitney C.W., Sause W., Bundy B.N., et al. Randomized comparison offluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999, 17:1339-1348.
41. Stehman F.B., Ali S., Keys H.M., et al. Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: Follow-up of a Gynecologic Oncology Group trial. Am J Obstet Gynecol 2007, 197:e1-e6.
42. Corn B.W., Hernandez E., Anderson L., et al. Phase I/II study of concomitant irradiation and carboplatin for locally advanced carcinoma of the uterine cervix: An interim report. Am J Clin Oncol 1996, 19:317-321.
43. Higgins R.V., Naumann W.R., Hall J.B., et al. Concurrent carboplatin with pelvic radiation therapy in the primary treatment of cervix cancer. Gynecol Oncol 2003, 89:499-503.
44. Dubay R.A., Rose P.G., O'Malley D.M., et al. Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer. Gynecol Oncol 2004, 94:121-124.
45. Cetina L., Garcia-Arias A., Uribe Mde J., et al. Concurrent chemoradiation with carboplatin for elderly, diabetic and hypertensive patients with locally advanced cervical cancer. Eur J Gynaecol Oncol 2008, 29:608-612.
46. Addeo D., Blank S., Muggia F., et al. Concurrent radiotherapy, paclitaxel and dose escalating carboplatin in the treatment of cervical cancer-a phase I study. Anticancer Res 2008, 28:3143-3146.
47. Lee M.Y., Wu H.G., Kim K., et al. Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix. Gynecol Oncol 2007, 104:95-99.
48. Pearcey R., Brundage M., Drouin P., et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 2002, 20:966-972.
49. Girinsky T., Rey A., Roche B., et al. Overall treatment time in advanced cervical carcinomas: A critical parameter in treatment outcome. Int J Radiat Oncol Biol Phys 1993, 27:1051-1056.
50. Perez C.A., Grigsby P.W., Castro-Vita H., et al. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1995, 32:1275-1288.
51. Petereit D.G., Sarkaria J.N., Chappell R., et al. The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys 1995, 32:1301-1307.
52. Lanciano R.M., Pajak T.F., Martz K., et al. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of-care study. Int J Radiat Oncol Biol Phys 1993, 25:391-397.
53. Jhingran A., Eifel P.J. Perioperative and postoperative complications of intracavitary radiation for FIGO stage I-III carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000, 46:1177-1183.
54. Lanciano R., Corn B., Martin E., et al. Perioperative morbidity of intracavitary gynecologic brachytherapy. Int J Radiat Oncol Biol Phys 1994, 29:969-974.
55. Viswanathan A.N., Erickson B., Rownd J. Image-based approaches to interstitial brachytherapy. Gynecologic radiation therapy: novel approaches to image-guidance and management 2011, 247-259. Springer, Berlin. 1st ed. A. Viswanathan, C. Kirisits, B. Erickson, R. Potter (Eds.).
56. Dimopoulos J.C., Kirisits C., Petric P., et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Clinical feasibility and preliminary results. Int J Radiat Oncol Biol Phys 2006, 66:83-90.
57. Jurgenliemk-Schulz I.M., Tersteeg R.J., Roesink J.M., et al. MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer. Radiother Oncol 2009, 93:322-330.
58. Viswanathan A.N., Creutzberg C., Craighead P., et al. International Brachytherapy Practice Patterns: A Survey of the Gynecologic Cancer Intergroup (GCIG). Int J Radiat Biol Phys 22 Dec 2010, Epub ahead of print.
59. Kubo H.D., Glasgow G.P., Pethel T.D., et al. High dose-rate brachytherapy treatment delivery: Report of the AAPM Radiation Therapy Committee Task Group No 59. Med Phys 1998, 25:375-403.
60. Davidson M.T., Yuen J., D'Souza D.P., et al. Optimization of high-dose-rate cervix brachytherapy applicator placement: The benefits of intraoperative ultrasound guidance. Brachytherapy 2008, 7:248-253.
61. Mayr N.A., Montebello J.F., Sorosky J.I., et al. Brachytherapy management of the retroverted uterus using ultrasound-guided implant applicator placement. Brachytherapy 2005, 4:24-29.
62. Sahinler I., Cepni I., Oksuz D.C., et al. Tandem application with transvaginal ultrasound guidance. Int J Radiat Oncol Biol Phys 2004, 59:190-196.
63. Rush S., Gottesman R., Lovecchio J. The use of intraoperative transabdominal ultrasound in gynecologic brachytherapy. Int J Radiat Oncol Biol Phys 1991, 21:1107.
64. Syed A., Puthawala A.A., Neblett D., et al. Transperineal interstitial intracavitary " syed-neblett" applicator in the treatment of carcinoma of the uterine cervix. Endocuriether Hypertherm 1986, 2:1-13.
65. Martinez A., Cox R.S., Edmundson G.K. A multiple-site perineal applicator (MUPIT) for treatment of prostatic, anorectal, and gynecologic malignancies. Int J Radiat Oncol Biol Phys 1984, 10:297-305.
66. Kirisits C., Lang S., Dimopoulos J., et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Design, application, treatment planning, and dosimetric results. Int J Radiat Oncol Biol Phys 2006, 65:624-630.
67. Mayr N.A., Tali E.T., Yuh W.T., et al. Cervical cancer: Application of MR imaging in radiation therapy. Radiology 1993, 189:601-608.
68. Viswanathan A.N., Dimopoulos J., Kirisits C., et al. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: Results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys 2007, 68:491-498.
69. Mayr N.A., Magnotta V.A., Ehrhardt J.C., et al. Usefulness of tumor volumetry by magnetic resonance imaging in assessing response to radiation therapy in carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1996, 35:915-924.
70. Schoeppel S.L., Ellis J.H., LaVigne M.L., et al. Magnetic resonance imaging during intracavitary gynecologic brachytherapy. Int J Radiat Oncol Biol Phys 1992, 23:169-174.
71. Olpin J., Tempany C. Imaging of gynecologic malignancies. Gynecologic radiation therapy: novel approaches to image-guidance and management 2011, 3-18. Springer, Berlin. 1st ed. A. Viswanathan, C. Kirisits, B. Erickson, R. Potter (Eds.).
72. Schoeppel S.L., LaVigne M.L., Martel M.K., et al. Three-dimensional treatment planning of intracavitary gynecologic implants: Analysis of ten cases and implications for dose specification. Int J Radiat Oncol Biol Phys 1994, 28:277-283.
73. Lin L.L., Mutic S., Low D.A., et al. Adaptive brachytherapy treatment planning for cervical cancer using FDG-PET. Int J Radiat Oncol Biol Phys 2007, 67:91-96.
74. Erickson B., Foley W.D., Gillin M., et al. Ultrasound guided transperineal interstitial implantation of pelvic malignancies: Description of the technique. Endocuriether Hypertherm 1995, 11:107-113.
75. Van Dyk S., Narayan K., Fisher R., et al. Conformal brachytherapy planning for cervical cancer using transabdominal ultrasound. Int J Radiat Oncol Biol Phys 2009, 75:64-70.
76. Viswanathan A.N., Moughan J., Small W., et al. Quality of cervical cancer brachytherapy implantation in RTOG prospective trials. Int J Radiat Oncol Biol Phys 2009, 75:S86-S87.
77. Katz A., Eifel P.J. Quantification of intracavitary brachytherapy parameters and correlation with outcome in patients with carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000, 48:1417-1425.
78. Eisbruch A., Johnston C.M., Martel M.K., et al. Customized gynecologic interstitial implants: CT-based planning, dose evaluation, and optimization aided by laparotomy. Int J Radiat Oncol Biol Phys 1998, 40:1087-1093.
79. Erickson B., Albano K., Gillin M. CT-guided interstitial implantation of gynecologic malignancies. Int J Radiat Oncol Biol Phys 1996, 36:699-709.
80. Viswanathan A.N., Cormack R., Holloway C.L., et al. Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer. Int J Radiat Oncol Biol Phys 2006, 66:91-99.
81. Erickson B., Albano K., Gillin M. Magnetic resonance imaging following interstitial implantation of pelvic malignancies. Radiat Oncol Invest 1996, 2:298-300.
82. Haie-Meder C., Potter R., Van Limbergen E., et al. Recommendations from gynaecological (GYN) GEC-ESTRO working group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005, 74:235-245.
83. Potter R., Haie-Meder C., Van Limbergen E., et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006, 78:67-77.
84. Nag S., Erickson B., Thomadsen B., et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000, 48:201-211.
85. Kirisits C., Potter R., Lang S., et al. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2005, 62:901-911.
86. Potter R., Dimopoulos J., Georg P., et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 2007, 83:148-155.
87. Dimopoulos J.C., Lang S., Kirisits C., et al. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys 2009, 75:56-63.
88. Sturdza A.E., Potter R. Clinical outcomes of 3d based external beam radiation and image guided brachytherapy. Gynecologic radiation therapy: novel approaches to image-guidance and management 2011, 263-282. Springer, Berlin. 1st ed. A. Viswanathan, C. Kirisits, B. Erickson, R. Potter (Eds.).
89. Viswanathan A.N., Erickson B.A. Three-dimensional imaging in gynecologic brachytherapy: A survey of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys 2010, 76:104-109.
90. Tod M., Meredith W. Treatment of cancer of the cervix uteri-a revised " Manchester method" Br J Radiol 1953, 26:252-257.
91. Potish R., Gerbi B., Engler G.P. Dose prescription, dose specification, and applicator geometry in intracavitary therapy 1995, Medical Physics Publishing, Madison, WI.
92. Georg P., Lang S., Dimopoulos J.C., et al. Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys 2011, 79:356-362.
93. Dose and volume specification for reporting intracavitary therapy in gynecology 1985, ICRU 38, ICRU 38, Bethesda, MD.
94. Pelloski C.E., Palmer M., Chronowski G.M., et al. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol BiolPhys 2005, 62:131-137.
95. Lee L.J., Sadow C.A., Russell A., et al. Correlation of point B and lymph node dose in 3D-planned high-dose-rate cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys 2009, 75:803-809.
96. Gebara W.J., Weeks K.J., Jones E.L., et al. Carcinoma of the uterine cervix: A 3D-CT analysis of dose to the internal, external and common iliac nodes in tandem and ovoid applications. Radiother Oncol 2000, 56:43-48.
97. Nag S., Chao C., Erickson B., et al. The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2002, 52:33-48.
98. Schwarz J.K., Siegel B.A., Dehdashti F., et al. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. JAMA 2007, 298:2289-2295.
99. Singh A.K., Grigsby P.W., Rader J.S., et al. Cervix carcinoma, concurrent chemoradiotherapy, and salvage of isolated paraaortic lymph node recurrence. Int J Radiat Oncol Biol Phys 2005, 61:450-455.